| Overview |
| bsm-90159r-50µL |
| Chondroitin sulfate proteoglycan 4 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human NG2 |
| 2250-2322/2322 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 1464 |
| Q6UVK1 |
| CSPG4; Chondroitin Sulfate Proteoglycan 4; MCSP; Melanoma-Associated Chondroitin Sulfate Proteoglycan; MEL-CSPG; HMW-MAA; CSPG4A ; MCSPG; MSK16; NG2; Chondroitin Sulfate Proteoglycan 4 (Melanoma-Associated); Melanoma Chondroitin Sulfate Proteoglycan; Chondroitin Sulfate Proteoglycan NG2; EC 2.7.8; EC 3.6.3 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz